Eton Pharmaceuticals (ETON) Change in Accured Expenses (2018 - 2025)

Eton Pharmaceuticals (ETON) has 8 years of Change in Accured Expenses data on file, last reported at $426000.0 in Q4 2025.

• For the quarter ending Q4 2025, Change in Accured Expenses fell 79.15% year-over-year to $426000.0; the trailing twelve-month figure through Dec 2025 stood at $1.0 million (down 31.87% YoY), and the FY2025 full-year result was $1.0 million, down 31.87% from the prior year.
• Change in Accured Expenses slipped to $426000.0 in Q4 2025, from $1.8 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $2.0 million in Q4 2024 to a low of -$1.6 million in Q1 2024.
• A 5-year average of $326850.0 and a median of $397000.0 in 2021 frame the typical range for Change in Accured Expenses.
• Across the five-year window, Change in Accured Expenses surged 4230.0% in 2023 and slumped 232.28% in 2024, its largest moves.
• Tracing ETON's Change in Accured Expenses over 5 years: stood at $120000.0 in 2021, then tumbled by 153.33% to -$64000.0 in 2022, then jumped by 2246.88% to $1.4 million in 2023, then soared by 48.69% to $2.0 million in 2024, then sank by 79.15% to $426000.0 in 2025.
• Business Quant data shows ETON's Change in Accured Expenses at $426000.0 in Q4 2025, $1.8 million in Q3 2025, and $172000.0 in Q2 2025.